Company / Net Debt per Share
Axsome Therapeutics, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$4.22
FY2025
5-year range
-$4.78 / -$0.99
FY2021-FY2025
Trend
-48.3%
vs FY2024
Sector context
#74 of 82
Health Care
What the data says
Among 82 Health Care companies, Axsome Therapeutics, Inc. is in the top 10% for net debt per share. Net Debt per Share has fluctuated over the past 10 years, ranging from $-5.96 in FY2019 to $0.49 in FY2016.
Based on SEC 10-K filings.
-4.22 in FY2025.
Increased from $-4.78 to $-4.22 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 82This company -$4.22 Sector average $13.70
▼
-130.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 48.3% year-over-year.
- Ranks #74 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2016.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.22 | -48.3% |
| FY2024 | -$2.84 | +40.6% |
| FY2023 | -$4.78 | -69.8% |
| FY2022 | -$2.82 | -183.6% |
| FY2021 | -$0.99 | +72.7% |
| FY2020 | -$3.64 | +38.8% |
| FY2019 | -$5.96 | -4524.1% |
| FY2018 | $0.13 | -54.0% |
| FY2017 | $0.29 | -40.8% |
| FY2016 | $0.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026